| 1 |
32585880 | Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates. | 2020 Jun 23 |
1 |
| 2 |
23599513 | P-glycoprotein should be considered as an additional factor contributing to opioid-induced respiratory depression in paediatrics: the buprenorphine example. | 2013 May |
1 |
| 3 |
22739506 | P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception. | 2012 Oct |
1 |
| 4 |
22975888 | Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice. | 2012 Dec |
6 |
| 5 |
19887017 | Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). | 2010 Aug |
2 |
| 6 |
17001553 | Role of human placental efflux transporter P-glycoprotein in the transfer of buprenorphine, levo-alpha-acetylmethadol, and paclitaxel. | 2006 Oct |
5 |